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ABSTRACT
G protein–coupled receptor (GPCR) internalization is crucial for the
termination of GPCR activity, and in some cases is associated with
G protein–independent signaling and endosomal receptor signal-
ing. To date, internalization has been studied in great detail for class
A GPCRs; whereas it is not well established to what extent the
observations can be generalized to class C GPCRs, including the
extracellular calcium-sensing receptor (CaSR). The CaSR is a pro-
totypical class C GPCR that maintains stable blood calcium (Ca21)
levels by sensingminute changes in extracellular freeCa21. It is thus
necessary that the activity of the CaSR is tightly regulated, even
while continuously being exposed to its endogenous agonist.
Previous studies have used overexpression of intracellular proteins
involved in GPCR trafficking, pathway inhibitors, and cell-surface
expression or functional desensitization as indirect measures to
investigate CaSR internalization. However, there is no general
consensus on the processes involved, and the mechanism of
CaSR internalization remains poorly understood. The current study
provides new insights into the internalization mechanism of the
CaSR. We have used a state-of-the-art time-resolved fluorescence
resonance energy transfer–based internalization assay to directly
measure CaSR internalization in real-time.We demonstrate that the
CaSR displays both constitutive and concentration-dependent
Ca21-mediated internalization. For the first time, we conclusively
show that CaSR internalization is sensitive to immediate
positive and negative modulation by the CaSR-specific allo-
steric modulators N-(3-[2-chlorophenyl]propyl)-(R)-a-methyl-
3-methoxybenzylamine (NPS R-568) and 2-chloro-6-[(2R)-2-
hydroxy-3-[(2-methyl-1-naphthalen-2-ylpropan-2-yl)amino]
propoxy]benzonitrile (NPS 2143), respectively. In addition,
we provide compelling evidence that CaSR internalization is
b-arrestin–dependent while interestingly being largely in-
dependent of Gq/11 and Gi/o protein signaling.
SIGNIFICANCE STATEMENT
A novel highly efficient cell-based real-time internalization assay
to show that calcium-sensing receptor (CaSR) internalization is
b-arrestin-dependent and sensitive to modulation by allosteric
ligands.
Introduction
The extracellular calcium-sensing receptor (CaSR) is a widely
expressed class C G protein–coupled receptor (GPCR) that is
essential for calcium homeostasis in the human body through
regulation of the synthesis and secretion of the calcium-elevating
parathyroid hormone (Brown et al., 1993; Brown, 2013). Several
natural occurring CaSR mutations have been identified in
patients suffering from calcium homeostasis-related disorders
(e.g., familial hypocalciuric hypercalcemia and autosomal dom-
inant hypocalcemia), thereby making the CaSR an attractive
drug target in diseases related to calcium and parathyroid
hormone imbalance (Brown, 2007; Hannan and Thakker,
2013). In 2004, the CaSR-specific positive allosteric modulator
(PAM) cinacalcet was the first allosteric GPCR drug to be
approved for clinical use. Cinacalcet effectively lowers elevated
parathyroid hormone levels in disorders linked to hyperpara-
thyroidism (Nemeth and Goodman, 2016). Recently, the CaSR
PAMetelcalcetide received regulatory approval for clinical use as
amore efficacious alternative for cinacalcet with a higher level of
compliance (Block et al., 2017; Patel andBridgeman, 2018; Xipell
et al., 2019). CaSR expression in tissues unrelated to calcium
homeostasis suggests that this receptor could also be a potential
therapeutic target for cardiovascular diseases, infertility, and
cancer (Ellinger, 2016; Tennakoon et al., 2016; Guo et al., 2018).
Nevertheless, the precise contribution of the CaSR in these
disease contexts remains uncertain.
GPCR endocytosis—commonly referred to as GPCR inter-
nalization—is a highly regulated process for removal of
GPCRs from the cell membrane into intracellular compart-
ments. Given the direct influence on GPCR cell-surface
This project has received funding from the European Union’s Horizon 2020
Research and Innovation Programme under [Grant 675228], Lundbeck
Foundation, Carlsberg Foundation, Augustinus Foundation, and Toyota
Foundation.
1Current affiliation: Monash Biomedicine Discovery Institute, Department
of Biochemistry and Molecular Biology, Monash University, Clayton,
Australia.
2I.M. and S.E.J. contributed equally to this work.
https://doi.org/10.1124/mol.119.116772.
ABBREVIATIONS: b2AR, b2-adrenergic receptor; CaSR, calcium-sensing receptor; GLP-1R, glucagon-like peptide 1 receptor; GPCR, G protein–coupled
receptor; HA, hemagglutinin; HBSS, Hanks’ balanced salt solution; HEK, human embryonic kidney; IP1, inositol monophosphate; KO, knockout; NAM,
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TR-FRET, time-resolved fluorescence resonance energy transfer; WT, wild type.
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expression, understanding the mechanism(s) of internaliza-
tion is of crucial importance for obtaining full comprehension
of GPCR signaling and function (Drake et al., 2006; Moore
et al., 2007). Internalization has been extensively studied in
class A GPCRs, where the most prevalent mechanism after
receptor activation includes kinase-mediated phosphorylation
of the GPCR C-terminus and intracellular loops followed by
b-arrestin recruitment and dynamin-driven internalization in
clathrin-coated pits (Moore et al., 2007). However, the in-
ternalization mechanism(s) in class B and C GPCRs remains
less well described.
In particular, the processes that underscore internalization
of class C GPCRs, including the CaSR, are poorly understood
and there is a lack of consensus in the current literature. Some
studies conclude that the CaSR can internalize and recycle to
the cell-surface independently of agonist activation (Reyes-
Ibarra et al., 2007; Zhuang et al., 2012), whereas others have
reported agonist-mediated internalization (Pi et al., 2005;
Lorenz et al., 2007). Additionally, Grant et al. (2011) stated that
constitutive (i.e., ligand-independent) CaSR internalization is
primarily followed by degradation rather than recycling. Re-
garding the mechanism underlying CaSR internalization, Pi
et al. (2005) and Lorenz et al. (2007) have conducted over-
expression and inhibition studies of intracellular proteins related
toGPCR trafficking, inwhich cell-surface expressionwasused as
an indirect measure of internalization. Both studies found that
CaSR interaction with kinases and b-arrestins was essential for
functional desensitization, but not for CaSR internalization (Pi
et al., 2005; Lorenz et al., 2007). Furthermore, by using non-
specific internalization inhibitors Holstein et al. (2004) have
shown that a PAMmay regulate CaSR internalization, although
this remains to be shown via direct measurement of CaSR
internalization.
In the present study, we aimed to delineate the mechanism
underlying CaSR internalization and to directly measure the
effects of allosteric ligands on CaSR internalization using
a real-time time-resolved fluorescence resonance energy
transfer (TR-FRET)–based internalization assay (Foster and
Bräuner-Osborne, 2018). This assay has previously been
applied to directly measure constitutive and agonist-
mediated internalization for receptors across different GPCR
classes, including the class A b2-adrenergic receptor (b2AR)
(Roed et al., 2014), class B glucagon-like peptide 1 receptor
(GLP-1R) (Roed et al., 2014, 2015), and class C GPRC6A
(Jacobsen et al., 2017a). By using CaSR mutants, selective G
protein inhibitors and b-arrestin1/2 and Gq/11 protein knock-
out (KO) cell lines, we demonstrate that CaSR internalization
is b-arrestin dependent, largely Gi/o and Gq/11 protein in-
dependent, and modulated by allosteric ligands.
Materials and Methods
Materials. Unless stated otherwise, all reagents were obtained
from Sigma-Aldrich (St. Louis, MO). Dulbecco’s modified Eagle’s
medium, dialyzed FBS, a mixture of 10,000 U/ml penicillin and
10,000 mg/ml streptomycin, Dulbecco’s PBS without Ca21 and Mg21,
Opti-MEM,Hanks’ balanced salt solution (HBSS) without Ca21, Mg21
and phenol red, Lipofectamine 2000, and pertussis toxin (PTX) were
obtained fromThermoFisher Scientific (Waltham,MA). The allosteric
modulator N-(3-[2-chlorophenyl]propyl)-(R)-a-methyl-3-methoxyben-
zylamine (NPS R-568) hydrochloride was purchased from Tocris
Bioscience (Bristol, UK) and 2-chloro-6-[(2R)-2-hydroxy-3-[(2-methyl-
1-naphthalen-2-ylpropan-2-yl)amino]propoxy]benzonitrile (NPS 2143)
hydrochloride was synthesized in-house as previously published
(Johansson et al., 2013). The selective Gq/11 inhibitor YM-254890
(CAS Number 568580-02-9) was purchased from Wako Chemicals
GmbH (Neuss, Germany). The Gq/11 KO and b-arrestin1/2 KO cells
were generated from human embryonic kidney (HEK) 293A cells
using CRISPR/Cas9 technology as previously described (Schrage
et al., 2015; Alvarez-Curto et al., 2016).
Plasmid DNA Constructs. The FLAG-SNAP-tagged b2AR
pEGFPN1 and FLAG-SNAP-tagged GLP-1R pEGFPN1 constructs
were a kind gift from Dr. Maria Waldhoer, InterAx Biotech AG (Roed
et al., 2014). These constructs contain an upstream sequence encoding
a T-cell CD8A signal peptide followed by a FLAG and SNAP tag. The
N-terminal FLAG and SNAP tag were inserted to allow expression
analysis and real-time internalization measurements, respectively.
FLAG-SNAP-tagged CaSR wild-type (WT) and mutant vectors were
generated by replacing the GLP-1R sequence of the FLAG-SNAP-
taggedGLP-1R pEGFPN1 construct with the CaSRWT, CaSR S170A,
or CaSR E837A sequence using the MluI-NotI restriction sites. The
FLAG-SNAP-tagged CaSRWT andmutant constructs were validated
using an inositol monophosphate (IP1) accumulation assay (Fig. 1A)
and expression analysis (Fig. 1B). Constructs containing human
b-arrestin1 (GenBank accession number NM_004041.4) and
b-arrestin2 (GenBank accession number NM_004313.3) were made
in-house as previously published (Gabe et al., 2018).
Cell Culture and Transfection. HEK293T,HEK293A,Gq/11 KO,
and b-arrestin1/2 KO cells were cultured at 37°C and 5% CO2 in
Dulbecco’s modified Eagle’s medium supplemented with 10% dialyzed
FBS and the 1% penicillin/streptomycin mixture. All cell lines were
confirmed as negative for mycoplasma contamination using the
LookOut Mycoplasma PCR Detection Kit (Sigma-Aldrich). Forty-
eight hours prior to assays, cells were transiently transfected at
a density of 17,000 cells/well in poly-D-lysine–coated 96-well plates.
White opaque 96-well culture plates (PerkinElmer, Waltham, MA)
were used for ELISA and clear tissue culture–treated 96-well plates
(Corning, Corning, NY) for IP1 and cAMP accumulation assays. For
the TR-FRET–based internalization assay, cells were transiently
transfected in white 96-well culture plates (Corning). For each well,
30 ng CaSR construct diluted in 25 ml Opti-MEMwas added to 0.25 ml
Lipofectamine 2000 diluted in 25 ml Opti-MEM after 5-minute
incubation at room temperature (RT). For b-arrestin coexpression
studies, cells were transfected with a total of 60 ng/well at a CaSR:
empty pEGFPN1 vector ratio of 1:1 as negative control and CaSR:
b-arrestin ratios of 1:1 and 2:1:1 for coexpression with one or both
b-arrestin subtypes, respectively. For the CaSR signaling and expres-
sion experiments inHEK293A andb-arrestin1/2KO cells presented in
Fig. 8, theHEK293A cells were transfectedwith a total of 30 ng/well at
a CaSR:empty pEGFPN1 vector ratio of 1:3. The DNA:lipofectamine
mixture was subsequently mixed and incubated at RT for 20 minutes
prior to addition to the assay plate (50 ml/well). Next, 100 ml/well of
cells diluted in culture media (17,000 cells/well) was added and the
assay plate was incubated for 48 hours at 37°C and 5% CO2.
ELISA for Cell-Surface Expression. Cell-surface expression
levels of the WT and mutant CaSR constructs were examined using
ELISA as described previously (Nørskov-Lauritsen et al., 2015). To
ensure correct cell-surface labeling, the GABAB receptor expression
system was used as a control. In brief, cells were fixed with 4% para-
formaldehyde inDulbecco’s PBS for 5minutes at RT andwashed twice
using wash buffer (Dulbecco’s PBS supplemented with 1 mM CaCl2
and 1 mMMgCl2). After fixation, all wells were incubated for at least
30 minutes at RT in blocking solution (ultrapure MilliQ water,
3% skim milk, 1 mM CaCl2, and 1 mM MgCl2 50 mM Trizma
hydrochloride solution, pH 7.4) followed by incubation for 45 minutes
with monoclonal anti-FLAG antibody (Sigma-Aldrich) diluted 1:
100,000 in blocking solution. Subsequently, cells were incubated for
45 minutes with horseradish peroxidase–conjugated anti-mouse IgG
antibody (Vector Laboratories Inc., Burlingame, CA) diluted 1:2000 in
blocking solution after which they were washed four times in blocking
solution and four times in wash buffer. Chemiluminescence was
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measured on an EnSpire plate reader (PerkinElmer) immediately
after addition of 10 ml/well SuperSignal ELISA Femto Substrate
(Thermo Fisher Scientific).
Inositol Monophosphate Accumulation Assay. IP1 accumula-
tion downstream from CaSR activation was measured using the
HTRF IP-One Assay Kit (Cisbio Bioassays, Codolet, France) as
previously published (Jacobsen et al., 2017b). In brief, cells were
washed once in 100 ml/well of assay buffer (HBSS and 20mMHEPES,
pH 7.4) prior to ligand stimulation for 30 minutes at 37°C. All ligands
were prepared in ligand buffer (HBSS and 20 mM HEPES, pH 7.4,
supplemented with 20 mM LiCl). Unless stated otherwise, studies
with allosteric modulators or the Gq/11 inhibitor YM-254890 cells were
preincubated for 30 minutes at 37°C prior to ligand stimulation in
ligand buffer supplemented with allosteric modulator or inhibitor and
a final DMSO concentration below 0.1%. After ligand stimulation, the
cells were washed with assay buffer (100 ml/well) and subsequently
lysed for 30 minutes at RT using 30 ml/well IP-One Conjugate & Lysis
buffer (Cisbio Bioassays). The lysed cells were diluted with 30 ml/well
assay buffer and 10 ml/well was transferred to a white 384-well
Optiplate (PerkinElmer). Next, 10 ml/well of detection solution (assay
buffer 1 2.5% IP1-d2 conjugate 1 2.5% anti-IP1 antibody Tb
31
cryptate) was added and the plate was incubated in the dark for
1 hour at RT prior to measurement on an EnVision multimode plate
reader (PerkinElmer). Emissions at 615 and 665 nm were measured
upon excitation at 340 nm. The resulting fluorescence resonance
energy transfer ratios (615/665 nm) were converted to IP1 concen-
trations through standard curve interpolation of an IP1 calibrator
provided with the assay kit.
cAMP Accumulation Assay. CaSR-dependent cAMP inhibition
was measured using the cAMP Dynamic 2 Assay Kit purchased from
Cisbio Bioassays. For PTX treatment, cells were pretreated with
80 ng/ml PTX 24 hours prior to assay. Ligandswere prepared in ligand
buffer (HBSS and 20 mM HEPES, pH 7.4, supplemented with 50 mM
isobutyl-1-methyl-xanthine and 0.05% DMSO) containing 1.5 mM
forskolin. On the day of the assay, cells were washed once with
100 ml/well assay buffer (HBSS and 20 mM HEPES, pH 7.4) followed
by ligand stimulation (50 ml/well) for 30 minutes at RT. After ligand
stimulation, the cells were washed once with 100 ml/well assay buffer
and then lysed for 30 minutes at RT using 30 ml/well cAMP Lysis &
Detection Buffer. The lysates were dilutedwith 30ml/well assay buffer
and 10 ml/well was transferred to a white small-volume 384-well plate
(Greiner Bio-One, Monroe). Then, 10 ml per well detection solution
(assay buffer 1 2.5% cAMP-d2 conjugate 1 2.5% anti-cAMP antibody
Eu31 cryptate) was added and the plate was incubated in the dark for
1 hour at RT prior to measurement on an EnVision multimode plate
reader (PerkinElmer). Emissions at 615 and 665 nm were measured
upon excitation at 340 nm. The resulting fluorescence resonance
energy transfer ratios (615/665 nm) were converted to cAMP concen-
trations through standard curve interpolation of a cAMP calibrator
provided with the assay kit.
TR-FRET–Based Real-Time Internalization Assay. CaSR in-
ternalization was measured using a TR-FRET–based real-time
internalization assay as previously published (Roed et al., 2014,
2015; Levoye et al., 2015; Jacobsen et al., 2017a; Foster and
Bräuner-Osborne, 2018; Gabe et al., 2018). For each well, cell-
surface–expressed SNAP-tagged receptors were labeled for 1 hour
with 50 ml 0.1 nM cell-impermeable donor fluorophore (SNAP lumi4-
Tb; Cisbio Bioassays) diluted in Opti-MEM. Labeling was performed
at 4°C to allow visualization of constitutive internalization, as done
previously for the class C GPCR GPRC6A (Jacobsen et al., 2017a). All
ligandswere prepared at 2 final concentration in assay buffer (HBSS
and 20 mM HEPES, pH 7.4), while the acceptor fluorophore (fluores-
cein-O-acetic acid) was diluted in assay buffer to a final concentration
of 40 nM. The prepared ligand and acceptor fluorophore solutionswere
preheated to 37°C prior to addition. After labeling, cells were washed
twice with 100 ml/well cold assay buffer. Subsequently, 50 ml/well
ligand and 50 ml/well 40 nM fluorescein-O-acetic acid solution were
added and internalization was measured immediately at 37°C on an
EnVision multimode plate reader (PerkinElmer). Emissions at 615
and 520 nm were measured every 6 minutes upon excitation at 340
nm. The level of internalization depicted in the figures represents the
donor over acceptor emission ratio (615/520 nm). When testing EDTA
orYM-254890, the reagentswere present in final concentration during
both labeling and real-time measurements. When testing PTX, cells
were pretreated for 24 hours with 80 ng/ml PTX prior to assay.
Data Analysis. Curve fitting and statistical analyses were per-
formed with Graphpad Prism 7 (Graphpad Software, San Diego, CA).
Concentration-response curves were fitted using the following four-
parameter nonlinear regression equation:
Response5
Bottom1 ðTop2BottomÞ

1110½logEC50 2 logðagonistÞ
n
In this equation, top and bottom are the response values obtained at
the top and bottom plateau of the concentration-response curve. The
EC50 value is defined as the agonist concentration necessary to elicit
a half-maximal response and the n value corresponds to the Hill slope.
For internalization data, each real-time trace was baseline corrected
prior to area under the curve measurement. The obtained area under
the curve values were normalized as described in the figure legends.
Statistical analyses were performed using one-way ANOVA followed
by Dunnett’s post-test or Tukey’s multiple comparisons test for
comparisons against one condition or multiple conditions, respec-
tively. Statistical significance is notated in the figures as follows: *P,
0.05, **P, 0.01, ***P, 0.001. For some data points, error bars are not
visible since they are smaller than the symbol size.
Results
The N-Terminal SNAP-Tag Does Not Interfere with
CaSR Functionality. In this study, CaSR internalization
was investigated using CaSR WT and the CaSR mutants
S170A and E837A that are located in the L-amino acid and
Fig. 1. Characterization of WT and mutant CaSR con-
structs. WT and mutant CaSR transiently expressed in
HEK293T cells were validated in an IP1 accumulation
assay and by expression analysis. (A) IP1 accumulation
measured after 30-minute stimulation with increasing
Ca21 concentrations. Data represent mean 6 S.E.M. of
three independent experiments performed in triplicate. (B)
Cell-surface expression of FLAG-SNAP-tagged CaSR WT
and mutant constructs obtained with anti-FLAG anti-
bodies in ELISA. Data are mean 6 S.E.M. of four experi-
ments performed in parallel with the IP1 accumulation or
internalization assay. The expression of CaSR WT was set
to 100% and mutants were compared with CaSRWT using
one-way ANOVA followed by Dunnett’s post-test (***P ,
0.001).
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allosteric ligand binding site, respectively. CaSR internaliza-
tion was assessed using a TR-FRET–based real-time inter-
nalization assay that requires the addition of an N-terminal
SNAP tag to the receptor of interest. Prior to internalization,
the FLAG-SNAP-tagged constructs were validated for their
agonist response using an IP1 accumulation assay (Fig. 1A)
and for their cell-surface expression using an ELISA (Fig. 1B).
To investigate whether the SNAP tag interfered with the
signaling capacity of the CaSR, FLAG-SNAP-tagged CaSR
WT was compared with hemagglutinin (HA)-tagged CaSR
WT, which we have previously characterized in detail
(Jacobsen et al., 2017b). In a functional IP1 accumulation
assay there was no difference in agonist potency of Ca21 for
the two receptor constructs (Fig. 1A; pEC50 values of 2.50 6
0.02 and 2.39 6 0.03 for FLAG-SNAP-CaSR WT and HA-
CaSR WT, respectively), thereby confirming that the SNAP
tag did not prevent Ca21-mediated activation of the Gq/11
pathway. We next used the FLAG-SNAP-CaSR construct to
study Ca21-mediated CaSR internalization.
The CaSR Displays Constitutive and Ca21-Mediated
Internalization. CaSR internalization was measured in the
absence and presence of its endogenous agonist Ca21 and
internalization was observed under both conditions (Fig. 2A).
Increasing Ca21 concentrations induced internalization in
a concentration-dependent manner (pEC50 of 2.48 6 0.04)
(Fig. 2B). Direct comparison with the IP1 accumulation data
(Fig. 1A) revealed that Ca21 triggers internalization andGq/11-
mediated activity of the CaSR with equal potency.
The physiologic ligands of the CaSR include essential
components of cell culture media and assay buffers such as
divalent cations (e.g., Ca21 andMg21) and L-amino acids (e.g.,
L-phenylalanine and L-tryptophan). Additionally, cells are
able to release such ligands either through passive or active
membrane transport (Meier et al., 2002; Brini and Carafoli,
2011). To determine whether the constitutive internalization
was mediated by divalent cations and/or L-amino acids re-
leased from the cells during the real-time assay, we employed
two strategies. First, EDTA was used to chelate extracellular
cations present during the internalization assay. Since
L-amino acids require the presence of Ca21 to activate the
CaSR, chelation of Ca21 by EDTA also indirectly eliminates
the amino acid–induced effects (Conigrave et al., 2000; Geng
et al., 2016). To test if EDTA had nonspecific activity on the
cells or assay, we used the FLAG-SNAP-b2AR as a control. As
shown in Fig. 2, C and D, 1 mM EDTA significantly reduced
the level of isoproterenol-mediated internalization (P , 0.01,
one-way ANOVA followed by Dunnett’s post-test), while
0.5 mM EDTA had no effect. Hence, 0.5 mM EDTA was used
during labeling and real-time internalization measurements
of the CaSR. The usage of 0.5 mM EDTA did not affect
constitutive internalization of the CaSR (Fig. 2, E and F).
These results indicate that constitutive internalization is not
caused by ambient divalent cations and L-amino acids but
rather is an inherent property of the CaSR.
Second, constitutive internalization was investigated using
a CaSR loss-of-function mutant, S170A. The S170 residue is
located in the highly conserved L-amino acid orthosteric
binding site, where it directly interacts with L-Trp according
to the crystal structures of the CaSR extracellular domain
(Geng et al., 2016; Zhang et al., 2016). Mutating this residue
has been shown to prevent Ca21-mediated signaling of the
CaSR (Bräuner-Osborne et al., 1999; Geng et al., 2016). In
agreement with the literature, FLAG-SNAP-CaSR S170A
abolished Ca21-mediated IP1 accumulation (Fig. 1A). Cell-
surface expression analysis by ELISA verified that the loss of
Ca21-mediated activity was not caused by a lack of cell-surface
expression. The surface expression of CaSR S170A was
marginally reduced relative to CaSR WT; however, this alone
could not explain the loss of function (Fig. 1B, P , 0.001, one-
way ANOVA followed by Dunnett’s post-test). In the internal-
ization assay, CaSR S170A internalized constitutively while
no Ca21-mediated internalization was observed (Fig. 2, G and
H). Moreover, constitutive internalization of CaSR S170A was
unaffected by the presence of 0.5 mM EDTA. Thus, the
constitutive internalization was not eliminated by mutating
the orthosteric ligand binding site or chelation of extracellular
ambient Ca21. These results strongly suggest that the CaSR
displays constitutive internalization.
Ca21-Mediated CaSR Internalization Is Modulated
by Allosteric Ligands. To study the effect of allosteric
ligands on CaSR internalization, wemeasured internalization
in the presence of the representative negative allosteric
modulator (NAM) NPS 2143 or PAM NPS R-568 (Fig. 3).
Ca21-mediated internalization of the CaSRwas reduced in the
presence of 5 mM NPS 2143 and enhanced in the presence of
5 mMNPS R-568. This concentration of NPS 2143 and NPS R-
568 was found to fully inhibit or potentiate the Ca21-induced
CaSR response in the IP1 accumulation assay, respectively
(Figs. 4A and 5A).
CaSR-specific NAMs and PAMs generally share an over-
lapping binding site in the seven-transmembrane domain.
Previous publications have revealed that the modulating
effects from both NPS 2143 and NPS R-568 can be eliminated
bymutating theE837 residue situatedwithin this overlapping
binding site (Hu et al., 2002, 2006; Petrel et al., 2004; Jacobsen
et al., 2017b). To determine if the observed modulation of
CaSR internalization was directly mediated by the NAM and
PAM, internalization and functional testing was performed
with FLAG-SNAP-CaSR E837A.
CaSR E837A cell-surface expression was equivalent to
CaSR WT as demonstrated by ELISA (Fig. 1B). Moreover,
the Ca21-induced effect on CaSR E837A was similar to CaSR
WT in both the IP1 accumulation assay (Fig. 1A) and the real-
time internalization assay (Fig. 3, D and E). Thus, mutating
E837 did not affect surface expression or Ca21-mediated
receptor activation and internalization.
In accordance with previously published studies, the
E837A mutant did prevent NPS 2143–mediated inhibition
and NPS R-568–mediated potentiation of Ca21-induced IP1
accumulation (Figs. 4B and 5B). When tested in the real-
time internalization assay, the modulating effects of NPS
2143 and NPS R-568 were likewise abolished for the Ca21-
mediated internalization of CaSR E837A (Figs. 4, E and F
and 5, E and F), while the Ca21-mediated internalization of
CaSR WT was subjected to NPS 2143-induced inhibition
and NPS R-568-induced potentiation as expected (Figs. 4, C
and D and 5, C and D). Furthermore, a small yet statisti-
cally significant increase in constitutive internalization
from NPS R-568 (Fig. 5D, P , 0.05, one-way ANOVA
followed by Tukey’s multiple comparisons test) was abro-
gated in CaSR E837A (Fig. 5, D and F). These data
demonstrate that the CaSR-specific NAM NPS 2143 and
PAMNPS R-568 are directly responsible for the modulation
of CaSR internalization.
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Fig. 2. The CaSR displays constitutive and concentration-dependent Ca21-mediated internalization. HEK293T cells were transiently transfected with
FLAG-SNAP-CaSRWT, orthosteric loss-of-function CaSRmutant (S170A), or FLAG-SNAP-b2-adrenergic receptor (b2AR). (A) Representative real-time
traces showing CaSR WT internalization in response to buffer and increasing Ca21 concentrations. (B) Area under the curve (AUC) plotted against the
Ca21 concentration. Data are mean 6 S.E.M. of four independent internalization experiments performed in triplicate. (C) Representative real-time
traces and (D) baseline-corrected AUC data grouped from three independent experiments of b2AR internalization upon stimulation with 1 mM
isoproterenol in the absence and presence of 0.5 or 1mMEDTA. (E–H)The effect of 0.5mMEDTA onCaSRWT (E andF) aswell as CaSRS170A (G andH)
internalization was measured in the absence (open symbols, constitutive internalization) or presence (closed symbols, Ca21-mediated internalization) of
10 mM Ca21. (E and G) Representative real-time traces and (F and H) normalized baseline-corrected AUC data grouped from three independent
experiments performed in triplicate are shown. Real-time internalization traces are presented as mean 6 S.D. of a single representative experiment
performed in triplicate. Statistical analysis was performed using one-way ANOVA followed by Dunnett’s post-test (D, F andH). Significance is notated as
follows: *P , 0.05; **P , 0.01; ***P , 0.001.
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Constitutive and Ca21-Mediated CaSR Internaliza-
tion Is Independent of G Protein Activation. It is widely
accepted that the CaSR interacts with the Gq/11 and Gi/o
protein families, although interaction with other G proteins
has also been reported (Thomsen et al., 2012). To elucidate the
mechanism of CaSR internalization, we investigated whether
activation of these G proteins drive CaSR internalization.
Commercially available natural products YM-254890 and
PTX were used to inhibit Gq/11- and Gi/o-mediated activity,
respectively (Campbell and Smrcka, 2018). As seen in Fig. 6A,
30-minute preincubation with 1 mMYM-254890 to block Gq/11-
dependent signaling reduced Ca21-mediated IP1 generation
via CaSR WT to the basal IP1 level. Similarly, the Ca
21-
mediated decrease in cAMP accumulation was abrogated by
24-hour preincubation with 80 ng/ml PTX (Fig. 6B).
Both G protein inhibitors did not affect constitutive CaSR
internalization (Fig. 6, C and D, open symbols). Preincubation
with PTX had no effect on Ca21-mediated internalization,
while a modest 20% decrease was observed in the presence of
YM-254890 (Fig. 6, C andD, closed symbols,P, 0.05, one-way
ANOVA followed by Dunnett’s post-test). Preincubation with
PTX and YM-254890 did not further suppress Ca21-mediated
internalization, demonstrating that the twoG protein families
do not compensate for each other.
As presented in Fig. 6, E–G, similar results were obtained in
CRISPR/Cas9 edited HEK293A cells lacking the Gq/11 pro-
tein (Gq/11 KO cells). In particular, both the constitutive and
Ca21-mediated internalizations were maintained in the Gq/11
KO cells, consistent with the pharmacologically blocked Gq/11
in YM-254890–treated HEK293A cells. Overnight PTX treat-
ment in the Gq/11 KO cells led to a slight reduction in Ca
21-
mediated internalization, but did not affect constitutive
internalization (Fig. 6, E–G). Collectively, these results
suggest that constitutive and Ca21-mediated CaSR internal-
ization is largely independent of Gq/11 or Gi/o activation.
CaSR Internalization Is Predominantly Driven by
b-Arrestin. To investigate the involvement of b-arrestin,
CaSR internalization was measured in a CRISPR/Cas9 edited
cell line lacking b-arrestin1 and b-arrestin2 (b-arrestin1/2
KO) (O’Hayre et al., 2017). By expressing the CaSR in both the
b-arrestin1/2 KO cell line and its parental cell line HEK293A,
it was demonstrated that constitutive internalization of the
CaSR was reduced, while the Ca21-mediated internalization
of the CaSR was abolished in the absence of b-arrestins
(Fig. 7A) despite having equivalent surface labeling of the
CaSR in both cell lines (data not shown).
To validate that the loss of Ca21-mediated internalization
was caused by the lack of b-arrestin expression, the two
b-arrestin subtypes were transiently expressed in the
b-arrestin1/2 KO cell line and CaSR internalization was
measured. The introduction of each b-arrestin subtype did
not affect CaSR surface labeling (data not shown). Constitu-
tive internalization was significantly enhanced by both
b-arrestin1 and b-arrestin2 (Fig. 7, B and D, one-way ANOVA
Fig. 3. CaSR internalization is allosterically modulated. Real-time internalization traces of HEK293T cells transiently transfected with FLAG-SNAP-
CaSRWT in response to increasing Ca21 concentrations without allosteric modulators (A), in the presence of 5 mMNPS 2143 (B), and in the presence of
5mMNPSR-568 (C). (D) Real-time internalization traces for increasing Ca21 concentrations without allosteric modulators recorded fromHEK293T cells
transiently transfected with FLAG-SNAP-CaSR E837A. Data are mean 6 S.D. of a single representative experiment performed in triplicate. (E) Area
under the curve (AUC) plotted against the Ca21 concentration. Data are mean 6 S.E.M. of three or four independent internalization experiments
performed in triplicate.
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followed by Dunnett’s post-test). Furthermore, the reintro-
duction of either b-arrestin1, b-arrestin2, or both b-arrestins
restored Ca21-mediated internalization in the b-arrestin1/2
KO cells (Fig. 7, C and D). These results demonstrate that
CaSR internalization is largely b-arrestin dependent.
In this study, NPS 2143 and NPS R-568 have been shown
to affect not only CaSR signaling but also internalization.
The question remains whether these allosteric ligands
modulate Ca21-mediated CaSR signaling because they
modulate internalization or vice versa. To investigate this,
wemeasured the immediate effects of NPS 2143 and NPS R-
568 on CaSR signaling in b-arrestin1/2 KO cells, where
Ca21-mediated internalization was shown to be abolished
(Fig. 8A). Despite slightly higher cell-surface expression
(Fig. 8B), the maximum Ca21-induced IP1 accumulation
response in the b-arrestin1/2 KO cells was lower than that
observed with the HEK293A cells. However, NPS 2143 and
NPS R-568 were still able to qualitatively modulate CaSR
signaling in the b-arrestin1/2 KO cell line to the same
extent as in the parental HEK293A cell line. Thus, removal
of b-arrestin1/2, and thereby Ca21-mediated internaliza-
tion, does not impair modulation of CaSR signaling by
allosteric ligands.
Discussion
In the present study, we demonstrate that the CaSR
displays constitutive and Ca21-mediated internalization,
which is b-arrestin dependent and sensitive to allosteric
modulators. In accordance with our results, several studies
have previously reported that the CaSR is constitutively
internalized (Reyes-Ibarra et al., 2007; Grant et al., 2011;
Zhuang et al., 2012). However, the potential impact of
ambient CaSR ligands such as extracellular cations or
L-amino acids was not addressed in these studies. In the
current study, we have shown that constitutive internaliza-
tion of the CaSR occurs independently of extracellular
cations and L-amino acids, since constitutive internalization
was not abolished by the chelating agent EDTA or the CaSR
loss-of-function mutant S170A.
To gain these new insights into CaSR internalization,
we have used a TR-FRET–based assay, which allows high-
throughput, sensitive, and readily quantified detection of
receptor internalization in real time (Foster and Bräuner-
Osborne, 2018). This assay provides a useful platform to
study the role of b-arrestin and allosteric modulation of
CaSR internalization in greater detail than was previously
possible. Indeed, there are inconsistencies in the literature
Fig. 4. The CaSR allosteric site E837Amutant abolishes NPS 2143–induced inhibition of Ca21-mediated CaSR internalization. (A) IP1 accumulation of
CaSR WT upon stimulation with 4 mM Ca21 and increasing NPS 2143 concentrations. (B) IP1 accumulation for CaSR WT and CaSR E837A upon
stimulation with increasing Ca21 concentrations in the absence or presence of 5 mMNPS 2143. (A and B) Data are mean6 S.E.M. of three independent
experiments performed in triplicate. (C–F) The effect of NPS 2143 on CaSRWT (C and D) as well as CaSRE837A (E and F) internalization wasmeasured
in the absence (open symbols, constitutive internalization) or presence (closed symbols, Ca21-mediated internalization) of 10 mM Ca21. (C and E) Real-
time traces and (D and F) normalized baseline-corrected area under the curve (AUC) data grouped from three independent experiments performed in
triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test. Real-time internalization traces are
presented as mean 6 S.D. of a single representative experiment performed in triplicate. Significance is notated as follows: *P , 0.05; ***P , 0.001.
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regarding the key processes and proteins involved in CaSR
internalization. Reyes-Ibarra et al. (2007) and Zhuang et al.
(2012) showed constitutive CaSR internalization followed by
recycling, while Grant et al. (2011) reported merely lyso-
somal degradation. In other studies, the CaSR has been
reported to undergo Ca21-mediated internalization (Pi et al.,
2005; Lorenz et al., 2007). These data have been generated
using a variety of approaches including receptor truncation/
mutations, trafficking and signaling inhibitors (e.g., tunica-
mycin and gallein), and overexpression or small interfering
RNA knockdown of proteins (such as b-arrestin1/2 or GPCR
kinases) (Pi et al., 2005; Lorenz et al., 2007; Reyes-Ibarra
et al., 2007; Grant et al., 2011, 2015; Zhuang et al., 2012),
which likely explain the differences in conclusions drawn.
Importantly, the majority of studies have used static meas-
ures of CaSR localization, including immunoprecipitation
(Reyes-Ibarra et al., 2007) or immunofluorescence-based
approaches (Zhuang et al., 2012), or have indirectly tracked
CaSR internalization by measuring changes in functional
desensitization and/or cell-surface expression (Pi et al.,
2005; Lorenz et al., 2007; Grant et al., 2011, 2015). These
approaches typically only allow a qualitative measure and
not, as in the current study, a detailed quantitative measure
of receptor internalization.
NPS R-568 and NPS 2143 are CaSR allosteric modulators
with well-characterized pharmacological profiles (Nemeth
et al., 1996; Nemeth, 2002), but their effect on CaSR
internalization has not been systematically investigated.
In the present study, we show that CaSR internalization is
negatively and positively modulated by NPS 2143 and NPS
R-568, respectively. These results are in agreement with
previous findings on other receptors reporting allosteric
modulation of ligand-mediated internalization for the class
A M1 and M4 muscarinic acetylcholine receptors (Leach
et al., 2010; Yeatman et al., 2014), D2 dopamine receptor
(Basu et al., 2013), cannabinoid receptor type 1 (Ahn et al.,
2012; Laprairie et al., 2015), and the class C metabotropic
glutamate receptor 7 (Pelkey et al., 2007). Furthermore,
NPS R-568 triggered a small but statistically significant
increase in constitutive CaSR internalization. We propose
that this could either be caused by positive modulation of
the small amounts of ambient agonist present during the
Fig. 5. The CaSR allosteric site E837A mutant abolishes NPS R-568–induced potentiation of constitutive and Ca21-mediated CaSR internalization. (A)
IP1 accumulation of CaSRWTupon stimulation with 2mMCa
21 and increasing NPSR-568 concentrations. (B) IP1 accumulation for CaSRWT andCaSR
E837A upon stimulation with increasing Ca21 concentrations in the absence or presence of 5 mM NPS R-568. Data are mean 6 S.E.M. of three
independent experiments performed in triplicate. (C–F) The effect of NPS R-568 on CaSRWT (C and D) as well as CaSR E837A internalization (E and F)
was measured in the absence (open symbols, constitutive internalization) or presence (closed symbols, Ca21-mediated internalization) of 2 mM Ca21.
(C and E) Real-time traces and (D and F) normalized baseline-corrected area under the curve (AUC) data grouped from three independent experiments
performed in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test. Real-time
internalization traces are presented as mean 6 S.D. of a single representative experiment performed in triplicate. Significance is notated as follows:
*P , 0.05; ***P , 0.001.
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assay or direct activation of the CaSR internalization
pathway.
Additionally, CaSRmodulators have been reported to affect
the biosynthesis and forward trafficking of WT and mutant
CaSR. For NPS 2143 and NPS R-568, a respective decrease or
increase in CaSR WT surface expression was obtained follow-
ing overnight exposure with the allosteric modulators (Huang
and Breitwieser, 2007; White et al., 2009; Cavanaugh et al.,
2010; Leach et al., 2013). Here, we further demonstrate that
these modulators affect CaSR internalization in a similar
manner, although immediately after agonist stimulation.
CaSR interaction with b-arrestin1 and 2 has previously
been shown to be crucial for functional desensitization, but
not for Ca21-mediated internalization (Pi et al., 2005;
Fig. 6. CaSR internalization is largely independent of G protein activation. HEK293T cells transiently transfected with FLAG-SNAP-CaSR WT were
pretreated for 30 minutes with 1 mM Gq/11 of inhibitor YM-254890 or 24 hours with 80 ng/ml of Gi/o inhibitor PTX. (A) Normalized IP1 accumulation
upon stimulation with 10 mMCa21 in the absence or presence of YM-254890. (B) Normalized cAMP accumulation upon stimulation with 10 mMCa21
in the absence or presence of PTX. (C) Real-time traces in the absence or presence of the G protein inhibitors for constitutive internalization (open
symbols, 0 mMCa21) and Ca21-mediated internalization (closed symbols, 10 mMCa21). (D) Normalized grouped area under the curve (AUC) data for
constitutive and Ca21-mediated internalization. Constitutive (E) and Ca21-mediated (F) real-time internalization traces of FLAG-SNAP-CaSR WT
transiently transfected in HEK293A or Gq/11 KO cells. (G) Normalized grouped AUC data after donor signal correction for constitutive and Ca
21-
mediated internalization. (A, B, D, and G) Data are mean 6 S.E.M. from three to five independent experiments performed in triplicate. (C, E, and F)
Real-time data are mean 6 S.D. of a single representative experiment performed in triplicate. Statistical analysis was performed using one-way
ANOVA followed by Tukey’s multiple comparisons test (A, B, and G) and one-way ANOVA followed by Dunnett’s post-test (D) (*P, 0.05; **P, 0.01;
***P , 0.001).
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Lorenz et al., 2007). Pi et al. (2005) and Lorenz et al. (2007)
used a flow cytometry method in which internalization was
indirectly measured as a loss in cell-surface expression. In
their studies, the potential involvement of b-arrestin was
determined by b-arrestin overexpression, which could mask
their importance since endogenously expressed b-arrestin in
the cells could already saturate the internalization pathway.
In the present study, we clearly demonstrate the requirement
for b-arrestin in Ca21-mediated CaSR internalization in cells
lacking both b-arrestin subtypes. In reciprocal experiments,
transfection with either b-arrestin1 or b-arrestin2 recovered
internalization of the CaSR. Interestingly, both constitutive
and Ca21-mediated internalizations are largely independent
of the Gq/11 and Gi/o signaling pathways, indicating that the
b-arrestins are recruited independently of the major CaSR G
protein pathways.
The CaSR PAM cinacalcet was the first allosteric GPCR
modulator to be approved for clinical use. As a result, drug
discovery for CaSR-related diseases has shifted interest
toward the development of allosteric drugs. To date, a great
number of allosteric ligands acting on the CaSR have been
reported with well-known pharmacological and efficacy and
safety profiles in clinical trials, but there is still limited
knowledge on the clinical importance of CaSR internaliza-
tion. For some GPCRs, constitutive internalization and
recycling ensure a constant pool of functional receptors at
the cellular surface (Hein et al., 1994; Mcdaniel et al., 2012;
Basagiannis and Christoforidis, 2016). The CaSR is charac-
terized by its constant or prolonged exposure to agonist, and
thus a persistent cell-surface expression of functional recep-
tors is required to retain responsiveness. Accordingly, con-
stitutive internalization and recycling has been observed for
the CaSR (Reyes-Ibarra et al., 2007; Zhuang et al., 2012) as
well as for the related class C metabotropic glutamate
receptor subtype 5 receptor (Trivedi and Bhattacharyya,
2012), GABAB receptor (Grampp et al., 2007; Vargas et al.,
2008), and GPRC6A (Jacobsen et al., 2017a). Grant et al.
(2011) propose an alternative strategy for the CaSR to
remain responsive, in which prolonged Ca21 exposure trig-
gers constitutive internalization followed by degradation
rather than recycling. Instead, the CaSR from a persistent
intracellularly available pool is directed to the cell surface
(Grant et al., 2011). Although we cannot investigate the
anterograde trafficking of the CaSR since our TR-FRET
assay requires labeling of cell-surface–expressed receptors,
our principal findings on CaSR modulators agree with this
hypothesis.
Interestingly, we find that agonist-induced IP1 signaling is
reduced in the b-arrestin1/2 KO cell line compared with the
parental HEK293A cell line, despite slightly increased re-
ceptor cell-surface expression in the former. This is in
accordance with recent studies investigating disease-causing
mutations of the adaptor protein-2s subunit, which impair
CaSR internalization, increase CaSR cell-surface expression,
and reduce CaSR signaling (Gorvin et al., 2018). These results
suggest that receptor internalization is required to obtain
a full IP1 response, which could be driven by sustained
signaling from internalized receptors (Gorvin et al., 2018), or
alternatively point to the requirement for receptor internali-
zation, dephosphorylation, and recycling to resensitize the
receptor for sustained effects (Ward and Riccardi, 2012).
However,more studies are needed to delineate themechanism
of this observation. Moreover, we find that the NAM and PAM
qualitatively modulate the IP1 response to the same level in
Fig. 7. Constitutive and Ca21-mediated CaSR internalizations are b-arrestin1/2 dependent. The b-arrestin1/2 KO cells and HEK239A cells were
transiently transfected with FLAG-SNAP-CaSRWT. (A) Constitutive (open symbols, 0mMCa21) and Ca21-mediated (closed symbols, 10mMCa21) real-
time traces of b-arrestin1/2 KO cells and HEK293A cells. Similar results were generated in at least two additional experiments. (B) Constitutive (open
symbols, 0 mM Ca21) and (C) Ca21-mediated (closed symbols, 10 mM Ca21) real-time internalization traces of b-arrestin1/2 KO cells transiently
cotransfected with empty vector, b-arrestin1, b-arrestin2, or a combination of both subtypes (b-arrestin1/2). (D)Normalized grouped area under the curve
(AUC) data for constitutive and Ca21-mediated internalization analyzed using one-way ANOVA followed by Dunnett’s post-test (*P, 0.05; **P, 0.01;
***P , 0.001). Real-time data presented in (A–C) are mean 6 S.D. of a single representative experiment performed in triplicate, while AUC data in (D)
are shown as mean 6 S.E.M. of three independent experiments performed in triplicate.
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both cell lines, demonstrating that PAM/NAM effects on
signaling are not downstream from modulating receptor
internalization or vice versa.
In conclusion, we demonstrate that the CaSR undergoes
both constitutive and Ca21-mediated internalization using
a TR-FRET–based real-time internalization assay. Ca21-
mediated CaSR internalization was shown to be concentration
dependent with a Ca21 potency equal to that determined for
Gq/11-mediated IP1 accumulation. In addition, this study
reveals that Ca21-mediated CaSR internalization is sensitive
to allosteric modulation, G protein independent, and largely
b-arrestin1/2 dependent. More studies are needed to deter-
mine whether b-arrestin and/or G protein involvement is
a universal phenomenon or specific to the HEK293 cellular
background (i.e., the dependence on expression levels of
receptor and intracellular signaling and scaffolding proteins).
Future experiments investigating CaSR internalization upon
stimulation with other CaSR-specific PAMs and NAMs could
determinewhether differences in pharmacological profiles can
be related to biased signaling and distinct effects on in-
ternalization. Overall, these findings contribute to the full
delineation of the mechanisms regulating CaSR signaling.
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